M&A Deal Summary

CollaGenex Pharmaceuticals Acquires SansRosa Pharmaceutical Development

On December 14, 2005, CollaGenex Pharmaceuticals acquired healthcare services company SansRosa Pharmaceutical Development

Acquisition Highlights
  • This is CollaGenex Pharmaceuticals’ 1st transaction in the Healthcare Services sector.
  • This is CollaGenex Pharmaceuticals’ 1st transaction in the United States.

M&A Deal Summary

Date 2005-12-14
Target SansRosa Pharmaceutical Development
Sector Healthcare Services
Buyer(s) CollaGenex Pharmaceuticals
Deal Type Add-on Acquisition

Target

SansRosa Pharmaceutical Development

United States
SansRosa Pharmaceutical Development, Inc. is a provider of dermatological products for the treatment of rosacea.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

CollaGenex Pharmaceuticals

Newtown, Pennsylvania, United States

Category Company
Sector Life Science
DESCRIPTION

CollaGenex Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the dental and dermatology markets.


DEAL STATS #
Overall 1 of 1
Sector: Healthcare Services M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: United States M&A 1 of 1
Year: 2005 M&A 1 of 1